|
Insider Trading: Myriad Genetics Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myriad Genetics Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Myriad Genetics Inc since year 2005. Table 2 shows the detailed insider transactions of Myriad Genetics Inc since 2005.
The reporting company's ticker symbol is MYGN.
The reporting company's CIK number is 899923.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $69,834,995.
The total value of stock exercises is $18,688,661.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Myriad Genetics Inc (MYGN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Myriad Genetics Inc (MYGN) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Myriad Genetics Inc (MYGN).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 0 | 0 | 32,000 | 2,254,133 | 27,128 | 381,806 |
| 2008-09 | 0 | 0 | 156,488 | 10,314,451 | 175,328 | 3,032,367 |
| 2008-08 | 0 | 0 | 76,745 | 5,131,242 | 76,745 | 802,705 |
| 2008-05 | 0 | 0 | 0 | 0 | 50 | 1,499 |
| 2008-04 | 0 | 0 | 0 | 0 | 3,500 | 51,835 |
| 2008-03 | 0 | 0 | 38,000 | 1,333,036 | 62,155 | 612,442 |
| 2008-02 | 0 | 0 | 49,200 | 1,923,782 | 61,726 | 623,098 |
| 2008-01 | 0 | 0 | 0 | 0 | 52,966 | 429,438 |
| 2007-12 | 0 | 0 | 62,506 | 3,065,511 | 34,900 | 588,496 |
| 2007-11 | 0 | 0 | 89,962 | 4,633,179 | 95,462 | 1,503,535 |
| 2007-10 | 0 | 0 | 125,247 | 7,240,819 | 90,604 | 1,227,681 |
| 2007-09 | 0 | 0 | 223,638 | 10,784,335 | 219,724 | 1,831,535 |
| 2007-08 | 0 | 0 | 39,352 | 1,692,436 | 38,773 | 618,681 |
| 2007-07 | 0 | 0 | 5,581 | 223,240 | 0 | 0 |
| 2007-06 | 0 | 0 | 7,500 | 283,454 | 20,000 | 271,250 |
| 2007-05 | 0 | 0 | 241,892 | 9,413,221 | 207,901 | 2,927,083 |
| 2007-04 | 0 | 0 | 5,000 | 180,387 | 0 | 0 |
| 2007-03 | 0 | 0 | 21,725 | 725,591 | 24,625 | 299,797 |
| 2007-02 | 0 | 0 | 5,626 | 208,162 | 5,626 | 28,833 |
| 2007-01 | 0 | 0 | 53,156 | 1,785,527 | 33,156 | 343,743 |
| 2006-12 | 0 | 0 | 20,000 | 618,000 | 0 | 0 |
| 2006-11 | 0 | 0 | 49,096 | 1,359,514 | 13,156 | 173,314 |
| 2006-10 | 0 | 0 | 13,588 | 375,861 | 8,588 | 43,028 |
| 2006-08 | 0 | 0 | 15,000 | 376,936 | 15,000 | 211,875 |
| 2006-06 | 0 | 0 | 27,000 | 673,104 | 42,444 | 525,244 |
| 2006-05 | 0 | 0 | 40,064 | 1,121,973 | 40,064 | 489,687 |
| 2006-04 | 0 | 0 | 35,556 | 872,956 | 35,556 | 249,994 |
| 2006-03 | 0 | 0 | 90,000 | 2,343,409 | 107,294 | 1,156,488 |
| 2006-02 | 0 | 0 | 34,032 | 851,825 | 24,032 | 263,207 |
| 2005-12 | 0 | 0 | 2,448 | 48,911 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Myriad Genetics Inc (MYGN)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-21 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Exercise | 5,128 | 19.50 | 99,996 |
| 2008-11-10 | Skolnick Mark H (Chief Scientific Officer) | Sale | 10,000 | 71.15 | 711,500 |
| 2008-11-10 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 10,000 | 4.78 | 47,810 |
| 2008-11-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 12,000 | 70.00 | 840,000 |
| 2008-11-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Exercise | 12,000 | 19.50 | 234,000 |
| 2008-11-04 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 70.26 | 702,633 |
| 2008-09-29 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 21,068 | 5.12 | 107,973 |
| 2008-09-25 | Evans James S (Chief Financial Officer) | Sale | 6,669 | 69.00 | 460,161 |
| 2008-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 15,000 | 68.54 | 1,028,137 |
| 2008-09-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 10,000 | 5.12 | 51,250 |
| 2008-09-19 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 992 | 66.00 | 65,472 |
| 2008-09-19 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 992 | 5.12 | 5,084 |
| 2008-09-19 | Wilson Linda S (Director) | Sale | 12,500 | 65.81 | 822,575 |
| 2008-09-19 | Wilson Linda S (Director) | Option Exercise | 12,500 | 28.02 | 350,275 |
| 2008-09-18 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 10,000 | 5.12 | 51,250 |
| 2008-09-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 32,380 | 66.08 | 2,139,647 |
| 2008-09-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 32,380 | 12.54 | 406,045 |
| 2008-09-17 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 500 | 66.49 | 33,245 |
| 2008-09-17 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 500 | 5.12 | 2,562 |
| 2008-09-16 | Skolnick Mark H (Chief Scientific Officer) | Sale | 19,500 | 66.00 | 1,287,000 |
| 2008-09-09 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Exercise | 3,000 | 15.28 | 45,840 |
| 2008-09-08 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 28,447 | 64.04 | 1,821,623 |
| 2008-09-08 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 28,447 | 28.63 | 814,390 |
| 2008-09-05 | Langer Dennis (Director) | Sale | 4,280 | 63.50 | 271,780 |
| 2008-09-05 | Langer Dennis (Director) | Option Exercise | 4,280 | 21.49 | 91,977 |
| 2008-09-05 | Gilbert Walter Phd (Director) | Sale | 10,000 | 63.31 | 633,100 |
| 2008-09-05 | Gilbert Walter Phd (Director) | Option Exercise | 10,000 | 25.74 | 257,350 |
| 2008-09-04 | Langer Dennis (Director) | Sale | 5,720 | 65.73 | 375,972 |
| 2008-09-04 | Langer Dennis (Director) | Option Exercise | 5,720 | 21.49 | 122,922 |
| 2008-09-04 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 6,714 | 17.68 | 118,737 |
| 2008-09-03 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 20,000 | 67.07 | 1,341,482 |
| 2008-09-03 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 20,000 | 16.64 | 332,800 |
| 2008-09-03 | Skolnick Mark H (Chief Scientific Officer) | Sale | 500 | 68.51 | 34,257 |
| 2008-09-02 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 9,727 | 28.16 | 273,912 |
| 2008-08-29 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 18,000 | 67.93 | 1,222,812 |
| 2008-08-29 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Exercise | 18,000 | 18.90 | 340,164 |
| 2008-08-29 | Marsh Richard M (V.P., General Counsel) | Sale | 11,198 | 68.26 | 764,353 |
| 2008-08-29 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 11,198 | 17.86 | 199,996 |
| 2008-08-29 | Meldrum Peter D (President & C.E.O.) | Sale | 15,998 | 68.07 | 1,088,926 |
| 2008-08-29 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 15,998 | 4.78 | 76,486 |
| 2008-08-27 | Harrison Robert Gardner (Chief Information Officer) | Sale | 4,085 | 65.90 | 269,201 |
| 2008-08-27 | Harrison Robert Gardner (Chief Information Officer) | Option Exercise | 4,085 | 11.09 | 45,306 |
| 2008-08-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 27,464 | 65.03 | 1,785,950 |
| 2008-08-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 27,464 | 5.12 | 140,753 |
| 2008-05-19 | Wilson Linda S (Director) | Option Exercise | 50 | 29.98 | 1,499 |
| 2008-04-14 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 3,500 | 14.81 | 51,835 |
| 2008-03-20 | Skolnick Mark H (Chief Scientific Officer) | Sale | 20,000 | 35.13 | 701,423 |
| 2008-03-20 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 20,000 | 9.31 | 186,249 |
| 2008-03-10 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 3,000 | 14.81 | 44,430 |
| 2008-03-10 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 10,000 | 5.12 | 51,250 |
| 2008-03-10 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 2,462 | 25.06 | 61,703 |
| 2008-03-04 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 8,693 | 11.64 | 101,186 |
| 2008-02-12 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 6,526 | 20.56 | 134,174 |
| 2008-02-07 | Skolnick Mark H (Chief Scientific Officer) | Sale | 25,000 | 39.21 | 977,391 |
| 2008-02-07 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 25,000 | 9.31 | 232,812 |
| 2008-02-01 | Evans James S (Chief Financial Officer) | Option Exercise | 6,000 | 5.12 | 30,750 |
| 2008-01-30 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 25,000 | 9.31 | 232,812 |
| 2008-01-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 18,644 | 7.03 | 131,084 |
| 2007-12-20 | Langer Dennis (Director) | Sale | 20,000 | 47.62 | 952,381 |
| 2007-12-20 | Langer Dennis (Director) | Option Exercise | 20,000 | 19.09 | 381,745 |
| 2007-12-20 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 4,900 | 7.03 | 34,451 |
| 2007-12-19 | Langer Dennis (Director) | Sale | 10,000 | 47.52 | 475,150 |
| 2007-12-19 | Langer Dennis (Director) | Option Exercise | 10,000 | 17.23 | 172,300 |
| 2007-12-07 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 2,692 | 50.71 | 136,319 |
| 2007-12-06 | Skolnick Mark H (Chief Scientific Officer) | Sale | 27,000 | 50.45 | 1,362,150 |
| 2007-12-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 1,122 | 48.30 | 54,192 |
| 2007-11-30 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 5,000 | 5.12 | 25,625 |
| 2007-11-30 | Wilson Linda S (Director) | Sale | 25,000 | 48.20 | 1,205,077 |
| 2007-11-30 | Wilson Linda S (Director) | Option Exercise | 23,900 | 10.76 | 257,190 |
| 2007-11-21 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 1,600 | 20.56 | 32,896 |
| 2007-11-05 | Gilbert Walter Phd (Director) | Sale | 35,000 | 52.82 | 1,847,267 |
| 2007-11-05 | Gilbert Walter Phd (Director) | Option Exercise | 35,000 | 18.09 | 638,901 |
| 2007-10-22 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 1,600 | 20.56 | 32,896 |
| 2007-10-15 | Evans James S (V.P. Finance) | Sale | 6,555 | 54.93 | 360,082 |
| 2007-10-15 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 4,886 | 55.21 | 269,130 |
| 2007-10-15 | Moyes Jay M (Chief Financial Officer) | Sale | 39,520 | 54.97 | 2,177,934 |
| 2007-10-15 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 39,520 | 12.54 | 495,578 |
| 2007-10-15 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 55.30 | 1,105,934 |
| 2007-10-11 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 10,000 | 57.26 | 572,631 |
| 2007-10-11 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Exercise | 10,000 | 19.50 | 195,000 |
| 2007-10-05 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 86.70 | 866,986 |
| 2007-10-05 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 10,000 | 13.45 | 134,480 |
| 2007-09-27 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,036 | 52.00 | 521,922 |
| 2007-09-27 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 10,036 | 14.81 | 148,633 |
| 2007-09-26 | Marsh Richard M (V.P., General Counsel) | Sale | 6,323 | 50.00 | 316,150 |
| 2007-09-26 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 6,323 | 12.54 | 79,290 |
| 2007-09-26 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 9,342 | 50.00 | 467,100 |
| 2007-09-26 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 9,342 | 4.78 | 44,664 |
| 2007-09-25 | Marsh Richard M (V.P., General Counsel) | Sale | 6,177 | 50.00 | 308,850 |
| 2007-09-25 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 6,177 | 12.54 | 77,459 |
| 2007-09-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 18,658 | 50.00 | 932,900 |
| 2007-09-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 18,658 | 4.78 | 89,203 |
| 2007-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 20,000 | 50.00 | 1,000,000 |
| 2007-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 20,000 | 5.12 | 102,500 |
| 2007-09-14 | Meldrum Peter D (President & C.E.O.) | Sale | 11,262 | 47.07 | 530,130 |
| 2007-09-14 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 11,262 | 9.31 | 104,877 |
| 2007-09-13 | Evans James S (V.P. Finance) | Sale | 3,914 | 47.20 | 184,730 |
| 2007-09-13 | Moyes Jay M (Chief Financial Officer) | Sale | 59,881 | 47.28 | 2,833,473 |
| 2007-09-13 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 59,881 | 8.94 | 526,293 |
| 2007-09-12 | Moyes Jay M (Chief Financial Officer) | Sale | 20,397 | 47.16 | 962,008 |
| 2007-09-12 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 20,397 | 6.46 | 131,702 |
| 2007-09-12 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 47.22 | 472,154 |
| 2007-09-12 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 10,000 | 9.31 | 93,125 |
| 2007-08-09 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 47.01 | 470,075 |
| 2007-08-09 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 10,000 | 14.81 | 148,100 |
| 2007-08-07 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 4,773 | 43.04 | 205,406 |
| 2007-08-07 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Exercise | 4,773 | 15.28 | 72,931 |
| 2007-08-07 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 9,000 | 40.25 | 362,250 |
| 2007-08-07 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Exercise | 9,000 | 19.50 | 175,500 |
| 2007-08-07 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 15,000 | 42.10 | 631,545 |
| 2007-08-07 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 15,000 | 14.81 | 222,150 |
| 2007-08-06 | Marsh Richard M (V.P., General Counsel) | Sale | 579 | 40.00 | 23,160 |
| 2007-07-16 | Marsh Richard M (V.P., General Counsel) | Sale | 5,581 | 40.00 | 223,240 |
| 2007-06-18 | Marsh Richard M (V.P., General Counsel) | Sale | 6,000 | 37.81 | 226,860 |
| 2007-06-15 | Moyes Jay M (Chief Financial Officer) | Sale | 1,500 | 37.73 | 56,594 |
| 2007-06-07 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 20,000 | 13.56 | 271,250 |
| 2007-05-31 | Skolnick Mark H (Chief Scientific Officer) | Sale | 30,000 | 38.29 | 1,148,622 |
| 2007-05-31 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 30,000 | 13.56 | 406,875 |
| 2007-05-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 10,000 | 40.00 | 400,000 |
| 2007-05-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 10,000 | 5.12 | 51,250 |
| 2007-05-09 | Gilbert Walter Phd (Director) | Sale | 30,000 | 38.05 | 1,141,608 |
| 2007-05-09 | Gilbert Walter Phd (Director) | Option Exercise | 30,000 | 10.70 | 321,112 |
| 2007-05-08 | Skolnick Mark H (Chief Scientific Officer) | Sale | 30,000 | 38.06 | 1,141,776 |
| 2007-05-08 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 30,000 | 13.56 | 406,875 |
| 2007-05-04 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 39.38 | 787,680 |
| 2007-05-03 | Hayes Arthur Hull Jr (Director) | Sale | 15,000 | 39.71 | 595,710 |
| 2007-05-03 | Hayes Arthur Hull Jr (Director) | Option Exercise | 15,000 | 13.00 | 195,000 |
| 2007-05-03 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 84,151 | 39.74 | 3,344,413 |
| 2007-05-03 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 84,151 | 17.07 | 1,436,247 |
| 2007-05-02 | Meldrum Peter D (President & C.E.O.) | Sale | 9,400 | 38.00 | 357,200 |
| 2007-05-01 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 8,750 | 37.00 | 323,750 |
| 2007-05-01 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 8,750 | 12.54 | 109,724 |
| 2007-05-01 | Marsh Richard M (V.P., General Counsel) | Sale | 3,991 | 37.50 | 149,662 |
| 2007-05-01 | Meldrum Peter D (President & C.E.O.) | Sale | 600 | 38.00 | 22,800 |
| 2007-04-16 | Marsh Richard M (V.P., General Counsel) | Sale | 5,000 | 36.08 | 180,387 |
| 2007-03-23 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Exercise | 5,400 | 14.75 | 79,650 |
| 2007-03-13 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 16,725 | 33.28 | 556,541 |
| 2007-03-13 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 16,725 | 11.64 | 194,679 |
| 2007-03-12 | Skolnick Mark H (Chief Scientific Officer) | Sale | 5,000 | 33.81 | 169,050 |
| 2007-03-07 | Wilson Linda S (Director) | Option Exercise | 2,500 | 10.19 | 25,468 |
| 2007-02-06 | Evans James S (Vice President Finance) | Sale | 5,626 | 37.00 | 208,162 |
| 2007-02-06 | Evans James S (Vice President Finance) | Option Exercise | 5,626 | 5.12 | 28,833 |
| 2007-01-16 | Simon S George (V.P. Business Development) | Sale | 5,000 | 35.09 | 175,439 |
| 2007-01-16 | Simon S George (V.P. Business Development) | Option Exercise | 5,000 | 12.54 | 62,699 |
| 2007-01-12 | Simon S George (V.P. Business Development) | Sale | 5,000 | 35.00 | 175,018 |
| 2007-01-12 | Simon S George (V.P. Business Development) | Option Exercise | 5,000 | 11.64 | 58,200 |
| 2007-01-12 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 35.00 | 350,000 |
| 2007-01-11 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 5,000 | 34.00 | 170,000 |
| 2007-01-11 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 5,000 | 12.54 | 62,699 |
| 2007-01-10 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 33.00 | 330,000 |
| 2007-01-09 | Moyes Jay M (Chief Financial Officer) | Sale | 8,156 | 32.50 | 265,070 |
| 2007-01-09 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 8,156 | 13.56 | 110,615 |
| 2007-01-03 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 5,000 | 32.00 | 160,000 |
| 2007-01-03 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Exercise | 5,000 | 5.12 | 25,625 |
| 2007-01-03 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 5,000 | 32.00 | 160,000 |
| 2007-01-03 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 5,000 | 4.78 | 23,905 |
| 2006-12-13 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 30.90 | 618,000 |
| 2006-11-20 | Moyes Jay M (Chief Financial Officer) | Sale | 4,800 | 30.00 | 144,001 |
| 2006-11-20 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 4,800 | 13.56 | 65,100 |
| 2006-11-17 | Moyes Jay M (Chief Financial Officer) | Sale | 333 | 30.00 | 9,990 |
| 2006-11-17 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 333 | 13.56 | 4,516 |
| 2006-11-16 | Moyes Jay M (Chief Financial Officer) | Sale | 3,023 | 30.00 | 90,690 |
| 2006-11-16 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 3,023 | 13.56 | 40,999 |
| 2006-11-15 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 4,176 | 29.00 | 121,104 |
| 2006-11-15 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 4,176 | 12.54 | 52,367 |
| 2006-11-10 | Gilbert Walter Phd (Director) | Sale | 26,297 | 26.93 | 708,158 |
| 2006-11-09 | Gilbert Walter Phd (Director) | Sale | 9,643 | 27.14 | 261,675 |
| 2006-11-07 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 824 | 29.00 | 23,896 |
| 2006-11-07 | Lanchbury Jerry S (Executive V.P. - Research) | Option Exercise | 824 | 12.54 | 10,332 |
| 2006-10-19 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 8,588 | 28.00 | 240,464 |
| 2006-10-19 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 8,588 | 5.01 | 43,028 |
| 2006-10-18 | Moyes Jay M (Chief Financial Officer) | Sale | 5,000 | 27.08 | 135,397 |
| 2006-08-30 | Hayes Arthur Hull Jr (Director) | Sale | 15,000 | 25.13 | 376,936 |
| 2006-08-30 | Hayes Arthur Hull Jr (Director) | Option Exercise | 15,000 | 14.12 | 211,875 |
| 2006-06-13 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 15,444 | 12.38 | 191,119 |
| 2006-06-07 | Skolnick Mark H (Chief Scientific Officer) | Sale | 27,000 | 24.93 | 673,104 |
| 2006-06-07 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 27,000 | 12.38 | 334,125 |
| 2006-05-08 | Skolnick Mark H (Chief Scientific Officer) | Sale | 21,436 | 28.00 | 600,225 |
| 2006-05-08 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 21,436 | 12.38 | 265,270 |
| 2006-05-05 | Simon S George (V.P. Business Development) | Sale | 10,000 | 28.02 | 280,164 |
| 2006-05-05 | Simon S George (V.P. Business Development) | Option Exercise | 10,000 | 10.74 | 107,400 |
| 2006-05-04 | Meldrum Peter D (President & C.E.O.) | Sale | 8,628 | 28.00 | 241,584 |
| 2006-05-04 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 8,628 | 13.56 | 117,017 |
| 2006-04-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 35,556 | 24.55 | 872,956 |
| 2006-04-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Exercise | 35,556 | 7.03 | 249,994 |
| 2006-03-23 | Evans James S (V.P. Finance) | Option Exercise | 1,500 | 5.12 | 7,687 |
| 2006-03-23 | Meldrum Peter D (President & C.E.O.) | Option Exercise | 9,230 | 11.64 | 107,437 |
| 2006-03-13 | Marsh Richard M (V.P., General Counsel) | Sale | 10,000 | 27.55 | 275,524 |
| 2006-03-13 | Marsh Richard M (V.P., General Counsel) | Option Exercise | 10,000 | 12.54 | 125,399 |
| 2006-03-10 | Skolnick Mark H (Chief Scientific Officer) | Option Exercise | 16,564 | 12.38 | 204,979 |
| 2006-03-09 | Gilbert Walter Phd (Director) | Sale | 6,300 | 26.00 | 163,800 |
| 2006-03-09 | Gilbert Walter Phd (Director) | Option Exercise | 6,300 | 13.00 | 81,900 |
| 2006-03-08 | Hayes Arthur Hull Jr (Director) | Sale | 25,000 | 25.74 | 643,597 |
| 2006-03-08 | Hayes Arthur Hull Jr (Director) | Option Exercise | 15,000 | 5.69 | 85,312 |
| 2006-03-08 | Gilbert Walter Phd (Director) | Sale | 36,600 | 25.85 | 946,239 |
| 2006-03-08 | Gilbert Walter Phd (Director) | Option Exercise | 36,600 | 10.19 | 372,862 |
| 2006-03-07 | Gilbert Walter Phd (Director) | Sale | 12,100 | 25.97 | 314,249 |
| 2006-03-07 | Gilbert Walter Phd (Director) | Option Exercise | 12,100 | 14.12 | 170,912 |
| 2006-02-27 | Moyes Jay M (Chief Financial Officer) | Sale | 2,900 | 25.21 | 73,100 |
| 2006-02-27 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 2,900 | 12.38 | 35,887 |
| 2006-02-13 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 25.00 | 250,000 |
| 2006-02-10 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 3,588 | 25.00 | 89,700 |
| 2006-02-10 | Hockett William A Iii (V. P. of Corp Communications) | Option Exercise | 3,588 | 5.12 | 18,388 |
| 2006-02-10 | Simon S George (V.P. Business Development) | Sale | 5,000 | 25.00 | 125,000 |
| 2006-02-10 | Simon S George (V.P. Business Development) | Option Exercise | 5,000 | 10.74 | 53,700 |
| 2006-02-10 | Moyes Jay M (Chief Financial Officer) | Sale | 12,544 | 25.03 | 314,025 |
| 2006-02-10 | Moyes Jay M (Chief Financial Officer) | Option Exercise | 12,544 | 12.38 | 155,232 |
| 2005-12-21 | Moyes Jay M (Chief Financial Officer) | Sale | 2,448 | 19.98 | 48,911 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Myriad Genetics Inc (symbol MYGN,
CIK number 899923) see
the Securities and Exchange Commission (SEC) website.
|
|
